HANTZ FINANCIAL SERVICES, INC.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1071061
SOUTHFIELD, MI
Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,234,288
-$112,962 QoQ
Shares Held
2,278
+0.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#433
of 875 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $25,049,020 across 25 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
852,184 | $7,950,876 | |
| 2 | ZTS |
Zoetis Inc.
|
81,045 | $5,823,893 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
269,650 | $4,322,489 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
41,890 | $1,419,233 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
2,278 | $1,234,288 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
6,706 | $1,130,229 | |
| 7 | VTRS |
Viatris Inc
|
30,373 | $482,323 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
4,265 | $473,159 |
All Filings in UTHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,234,288 | 2,278 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,347,250 | 2,272 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $764,982 | 1,570 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $394,476 | 941 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $70,688 | 246 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,699 | 12 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||